IFM Investors Pty Ltd Boosts Position in DocuSign, Inc. (NASDAQ:DOCU)

IFM Investors Pty Ltd lifted its position in DocuSign, Inc. (NASDAQ:DOCUFree Report) by 18.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,191 shares of the company’s stock after buying an additional 6,319 shares during the quarter. IFM Investors Pty Ltd’s holdings in DocuSign were worth $2,393,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Capital Analysts LLC boosted its holdings in DocuSign by 781.7% in the 4th quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after purchasing an additional 469 shares during the period. BluePath Capital Management LLC purchased a new stake in shares of DocuSign in the 3rd quarter valued at about $32,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of DocuSign during the 4th quarter valued at about $32,000. Performa Ltd US LLC grew its holdings in shares of DocuSign by 50.0% during the third quarter. Performa Ltd US LLC now owns 825 shares of the company’s stock worth $35,000 after purchasing an additional 275 shares in the last quarter. Finally, Register Financial Advisors LLC bought a new position in shares of DocuSign in the first quarter worth approximately $37,000. 77.64% of the stock is currently owned by institutional investors.

Insider Activity

In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total transaction of $470,553.60. Following the transaction, the chief executive officer now owns 111,767 shares in the company, valued at approximately $6,847,964.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 7,765 shares of the stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $53.31, for a total value of $413,952.15. Following the completion of the transaction, the chief executive officer now directly owns 104,002 shares of the company’s stock, valued at approximately $5,544,346.62. The disclosure for this sale can be found here. Over the last three months, insiders have sold 54,871 shares of company stock valued at $3,176,199. Company insiders own 17.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on DOCU. Royal Bank of Canada reissued a “sector perform” rating and issued a $59.00 price target on shares of DocuSign in a research note on Friday, April 12th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a research note on Friday, April 12th. JMP Securities reiterated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a report on Friday, April 12th. UBS Group raised DocuSign from a “sell” rating to a “neutral” rating and raised their price objective for the company from $48.00 to $62.00 in a report on Friday, April 12th. Finally, Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, DocuSign has a consensus rating of “Hold” and a consensus price target of $60.25.

View Our Latest Analysis on DocuSign

DocuSign Price Performance

DocuSign stock traded down $0.15 during trading hours on Friday, reaching $57.20. The stock had a trading volume of 1,117,148 shares, compared to its average volume of 1,479,879. The company has a fifty day simple moving average of $56.49 and a 200-day simple moving average of $52.65. DocuSign, Inc. has a 52 week low of $38.11 and a 52 week high of $64.76. The stock has a market cap of $11.75 billion, a PE ratio of 158.89, a PEG ratio of 4.96 and a beta of 0.89.

DocuSign (NASDAQ:DOCUGet Free Report) last posted its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The company had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million. Research analysts predict that DocuSign, Inc. will post 0.87 earnings per share for the current fiscal year.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.